Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition

George Han, Long N. Nguyen, Chitralekha MacHerla, Yuling Chi, Joel M. Friedman, Joshua D. Nosanchuk, Luis R. Martinez

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Wound healing is a complex process that involves coordinated interactions between diverse immunological and biological systems. Long-term wounds remain a challenging clinical problem, affecting approximately 6 million patients per year, with a high economic impact. To exacerbate the problem, these wounds render the individual susceptible to life-threatening microbial infections. Because current therapeutic strategies have proved suboptimal, it is imperative to focus on new therapeutic approaches and the development of technologies for both short- and long-term wound management. In recent years, nitric oxide (NO) has emerged as a critical molecule in wound healing, with NO levels increasing rapidly after skin damage and gradually decreasing as the healing process progresses. In this study, we examined the effects of a novel NO-releasing nanoparticle technology on wound healing in mice. The results show that the NO nanoparticles (NO-np) significantly accelerated wound healing. NO-np modified leukocyte migration and increased tumor growth factor-β production in the wound area, which subsequently promoted angiogenesis to enhance the healing process. By using human dermal fibroblasts, we demonstrate that NO-np increased fibroblast migration and collagen deposition in wounded tissue. Together, these data show that NO-releasing nanoparticles have the ability to modulate and accelerate wound healing in a pleiotropic manner.

Original languageEnglish (US)
Pages (from-to)1465-1473
Number of pages9
JournalAmerican Journal of Pathology
Volume180
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Wound Healing
Nanoparticles
Nitric Oxide
Collagen
Fibroblasts
Wounds and Injuries
Technology
Skin
Intercellular Signaling Peptides and Proteins
Leukocytes
Economics
Therapeutics
Infection
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. / Han, George; Nguyen, Long N.; MacHerla, Chitralekha; Chi, Yuling; Friedman, Joel M.; Nosanchuk, Joshua D.; Martinez, Luis R.

In: American Journal of Pathology, Vol. 180, No. 4, 04.2012, p. 1465-1473.

Research output: Contribution to journalArticle

Han, George ; Nguyen, Long N. ; MacHerla, Chitralekha ; Chi, Yuling ; Friedman, Joel M. ; Nosanchuk, Joshua D. ; Martinez, Luis R. / Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. In: American Journal of Pathology. 2012 ; Vol. 180, No. 4. pp. 1465-1473.
@article{7894457fdb6f439db6b0188ea8ea7e12,
title = "Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition",
abstract = "Wound healing is a complex process that involves coordinated interactions between diverse immunological and biological systems. Long-term wounds remain a challenging clinical problem, affecting approximately 6 million patients per year, with a high economic impact. To exacerbate the problem, these wounds render the individual susceptible to life-threatening microbial infections. Because current therapeutic strategies have proved suboptimal, it is imperative to focus on new therapeutic approaches and the development of technologies for both short- and long-term wound management. In recent years, nitric oxide (NO) has emerged as a critical molecule in wound healing, with NO levels increasing rapidly after skin damage and gradually decreasing as the healing process progresses. In this study, we examined the effects of a novel NO-releasing nanoparticle technology on wound healing in mice. The results show that the NO nanoparticles (NO-np) significantly accelerated wound healing. NO-np modified leukocyte migration and increased tumor growth factor-β production in the wound area, which subsequently promoted angiogenesis to enhance the healing process. By using human dermal fibroblasts, we demonstrate that NO-np increased fibroblast migration and collagen deposition in wounded tissue. Together, these data show that NO-releasing nanoparticles have the ability to modulate and accelerate wound healing in a pleiotropic manner.",
author = "George Han and Nguyen, {Long N.} and Chitralekha MacHerla and Yuling Chi and Friedman, {Joel M.} and Nosanchuk, {Joshua D.} and Martinez, {Luis R.}",
year = "2012",
month = "4",
doi = "10.1016/j.ajpath.2011.12.013",
language = "English (US)",
volume = "180",
pages = "1465--1473",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition

AU - Han, George

AU - Nguyen, Long N.

AU - MacHerla, Chitralekha

AU - Chi, Yuling

AU - Friedman, Joel M.

AU - Nosanchuk, Joshua D.

AU - Martinez, Luis R.

PY - 2012/4

Y1 - 2012/4

N2 - Wound healing is a complex process that involves coordinated interactions between diverse immunological and biological systems. Long-term wounds remain a challenging clinical problem, affecting approximately 6 million patients per year, with a high economic impact. To exacerbate the problem, these wounds render the individual susceptible to life-threatening microbial infections. Because current therapeutic strategies have proved suboptimal, it is imperative to focus on new therapeutic approaches and the development of technologies for both short- and long-term wound management. In recent years, nitric oxide (NO) has emerged as a critical molecule in wound healing, with NO levels increasing rapidly after skin damage and gradually decreasing as the healing process progresses. In this study, we examined the effects of a novel NO-releasing nanoparticle technology on wound healing in mice. The results show that the NO nanoparticles (NO-np) significantly accelerated wound healing. NO-np modified leukocyte migration and increased tumor growth factor-β production in the wound area, which subsequently promoted angiogenesis to enhance the healing process. By using human dermal fibroblasts, we demonstrate that NO-np increased fibroblast migration and collagen deposition in wounded tissue. Together, these data show that NO-releasing nanoparticles have the ability to modulate and accelerate wound healing in a pleiotropic manner.

AB - Wound healing is a complex process that involves coordinated interactions between diverse immunological and biological systems. Long-term wounds remain a challenging clinical problem, affecting approximately 6 million patients per year, with a high economic impact. To exacerbate the problem, these wounds render the individual susceptible to life-threatening microbial infections. Because current therapeutic strategies have proved suboptimal, it is imperative to focus on new therapeutic approaches and the development of technologies for both short- and long-term wound management. In recent years, nitric oxide (NO) has emerged as a critical molecule in wound healing, with NO levels increasing rapidly after skin damage and gradually decreasing as the healing process progresses. In this study, we examined the effects of a novel NO-releasing nanoparticle technology on wound healing in mice. The results show that the NO nanoparticles (NO-np) significantly accelerated wound healing. NO-np modified leukocyte migration and increased tumor growth factor-β production in the wound area, which subsequently promoted angiogenesis to enhance the healing process. By using human dermal fibroblasts, we demonstrate that NO-np increased fibroblast migration and collagen deposition in wounded tissue. Together, these data show that NO-releasing nanoparticles have the ability to modulate and accelerate wound healing in a pleiotropic manner.

UR - http://www.scopus.com/inward/record.url?scp=84859074352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859074352&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.12.013

DO - 10.1016/j.ajpath.2011.12.013

M3 - Article

VL - 180

SP - 1465

EP - 1473

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -